Lastly, we found that high NR2F6 protein expression was significantly correlated with shorter OS in the LNM-free subgroup, which suggests that NR2F6 might be a potential predictive biomarker of poor OS in patients with cervical cancer without LNM. This evidence concerns the gene NR2F6 and cervical cancer.